JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB53727

Anti-TGF beta 3 antibody

Be the first to review this product! Submit a review

|

(2 Publications )

Rabbit Polyclonal TGF beta 3 antibody. Suitable for WB and reacts with African green monkey samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human TGFB3.
1 Images
Western blot - Anti-TGF beta 3 antibody (AB53727)
  • WB

Unknown

Western blot - Anti-TGF beta 3 antibody (AB53727)

The active molecule is a nonglycosylated, homodimer comprised of 13-kDa polypeptide chains linked by disulphide bonds.

All lanes:

Western blot - Anti-TGF beta 3 antibody (ab53727) at 1/500 dilution

Lane 1:

extracts from COS7 cells

Lane 2:

extracts from COS7 cells with immunizing peptide

Predicted band size: 47 kDa

Observed band size: 11 kDa,65 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

African green monkey

Applications

WB

applications

Immunogen

Synthetic Peptide within Human TGFB3. The exact immunogen used to generate this antibody is proprietary information.

P10600

Specificity

Detects endogenous levels of total TGF ß3 protein.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "African green monkey": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transforming growth factor beta-3 proprotein : Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains, which constitute the regulatory and active subunit of TGF-beta-3, respectively.. Latency-associated peptide. Required to maintain the Transforming growth factor beta-3 (TGF-beta-3) chain in a latent state during storage in extracellular matrix (By similarity). Associates non-covalently with TGF-beta-3 and regulates its activation via interaction with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control activation of TGF-beta-3 (By similarity). Interaction with integrins results in distortion of the Latency-associated peptide chain and subsequent release of the active TGF-beta-3 (By similarity).. Transforming growth factor beta-3 : Multifunctional protein that regulates embryogenesis and cell differentiation and is required in various processes such as secondary palate development (By similarity). Activation into mature form follows different steps : following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains remain non-covalently linked rendering TGF-beta-3 inactive during storage in extracellular matrix (By similarity). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1 and LRRC32/GARP that control activation of TGF-beta-3 and maintain it in a latent state during storage in extracellular milieus (By similarity). TGF-beta-3 is released from LAP by integrins : integrin-binding results in distortion of the LAP chain and subsequent release of the active TGF-beta-3 (By similarity). Once activated following release of LAP, TGF-beta-3 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (By similarity).
See full target information TGFB3

Alternative Names

Transforming growth factor beta-3 proprotein, TGFB3

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Molecular biology of the cell 35:ar10 PubMed37991902

2023

Excess phosphoserine-129 α-synuclein induces synaptic vesicle trafficking and declustering defects at a vertebrate synapse.

Applications

Unspecified application

Species

Unspecified reactive species

Jaqulin N Wallace,Zachary C Crockford,Cristina Román-Vendrell,Emily B Brady,Christian Hoffmann,Karina J Vargas,Mariana Potcoava,M Elizabeth Wegman,Simon T Alford,Dragomir Milovanovic,Jennifer R Morgan

Nature communications 13:3275 PubMed35672400

2022

Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Toshiyuki Ko,Seitaro Nomura,Shintaro Yamada,Kanna Fujita,Takanori Fujita,Masahiro Satoh,Chio Oka,Manami Katoh,Masamichi Ito,Mikako Katagiri,Tatsuro Sassa,Bo Zhang,Satoshi Hatsuse,Takanobu Yamada,Mutsuo Harada,Haruhiro Toko,Eisuke Amiya,Masaru Hatano,Osamu Kinoshita,Kan Nawata,Hiroyuki Abe,Tetsuo Ushiku,Minoru Ono,Masashi Ikeuchi,Hiroyuki Morita,Hiroyuki Aburatani,Issei Komuro
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com